A B S T R A C T Experimental thrombocytopenia results in endothelial alterations associated with bleeding. In this study prednisone was shown to prevent or reverse these changes, which supports the clinical inference that adrenocorticosteroids decrease capillary fragility in thrombocytopenia. Rabbits (3-4 kg), intraperitoneally injected with busulfan, developed 98-99% reductions in platelet count and hemorrhaged profusely. Orally administered prednisone (0.2 mg/kg or 1.0 mg/kg daily) reduced bleeding despite persistent thrombocytopenia. Tongue biopsies obtained after 3 days of prednisone treatment were examined by electron microscopy. Normal rabbits served as controls. 25 consecutive capillaries or venules from each of four animals in the control group and each of five experimental groups were examined for fenestrations, "thin spots" (<800 A thick), and mean wall thickness as determined by planimetry. Vessels from control animals had no thin spots or fenestrations, and the mean vessel wall thickness was 4,254±105 A SEM. The 100 vessels from the thrombocytopenic animals had a mean vessel wall thickness of 2,081±218 A (P < 0.001), and 42 had thin spots of fenestrations. After administration of the smaller dosage of prednisone, the mean vessel wall thickness increased to 3,556±40 A (P < 0.001), and only nine vessels had thin spots or fenestrations. With the larger dosage, only six vessels had thin spots or fenestrations and the mean vessel wall thickness of this group increased to 3,704+206 A (P < 0.005). All preparations demonstrated normal endothelial junctions. The data are consistent with the hypothesis that the bleeding of thrombocytopenia is caused by al-A preliminary report of a part of this work has been pub- Induction ofthrombocytopenia. Peripheral blood platelet counts in normal rabbits were 400,000-600,000/mm3 as determined by Coulter Counter (Coulter Electronics Inc., Hialeah, Fla.) (7) . In the previous report (3), thrombocytopenia had been induced with antiplatelet serum. Despite its effectiveness, platelet reduction was intermittent, so the degree of thrombocytopenia was variable. In the present study, predictable, stable thrombocytopenia was induced by intraperitoneal administration of busulfan (Myleran, Burroughs Wellcome Co., Research Triangle Park, N.C.) 50 mg/kg, according to the method of Evensen and co-workers (8) . Endothelial changes identical with those associated with thrombocytopenia induced by antiplatelet serum were achieved with busulfan or irradiation (9). 13 or 14 days after the first injection of busulfan, severe .thrombocytopenia (s5,000/mm3) developed and spontaneous hemorrhage of the mucocutaneous membranes was noted. Approximately onefifth of the thrombocytopenic animals died from hemorrhage.
Experimental preparations. Six groups of four animals each were prepared for study. (11) .
RESULTS
Group A: normal microvascular endothelium. Fig.  3 a shows a normal capillary at low magnification. Normal endothelium at a higher magnification is shown in Fig. 1 a. The first column of Fig. 4 Group B: endothelium from normal animals given prednisone for 5 days. These capillaries appeared normal. The mean wall thickness was 3,978+59 A (Table I) . Neither thin spots nor fenestrations were observed.
Group C: vessels from thrombocytopenic animals. Biopsies were performed after 3 days of maximal thrombocytopenia while the platelet count remained <5,000/ mm3. Gross alterations of capillary endothelial structure, as previously reported (3), were noted and are illustrated in Figs. 1 b, 1 c, and 3 b. Thin spots or fenestrations or both were seen in 42 of 100 consecutive vessels (Table I ). The individual mean thicknesses of vessel walls are shown in Fig. 4 . The calculated mean wall thickness was 2,081+218 A (Table I) . This is significantly thinner compared with the normal control group (P < 0.001).
Group D: vessels from animals treated with pred- (3) was not observed in this adrenocorticosteroid-treated animal. Groups E and F: vessels from animals treated with low or high dosage of prednisone after thrombocytopenia. After maximal thrombocytopenia was achieved, prednisone (0.2 mg/kg or 1.0 mg/kg) was orally given once a day for 3 days. Several animals that were hemorrhaging before prednisone administration ceased bleeding, and petechiae cleared within 24 h after administration ofthe medication although the platelet count remained at <5,000/mm3. The individual mean thickness of vessel walls is shown in Fig. 4 . The mean wall thickness was 3,556±40 A for the low dosage and 3,704±206 A for the high dosage of prednisone. Noteworthy is the decrease in thin spots and fenestrations as shown in Table I . The difference in vessel wall thickness between groups that received low or high dosage of prednisone was not statistically 1132 C. S. Kitchens significant (P > 0.500), but vessels from rabbits in these two groups were significantly thicker than the vessels from thrombocytopenic animals that did not receive prednisone (P < 0.001 and P < 0.005, respectively). DISCUSSION The prolonged, severe, and predictable thrombocytopenia after busulfan administration facilitated this experimental design. Endothelial abnormalities were identical with those observed when thrombocytopenia was induced by antiplatelet serum (3) or irradiation (9) . In addition, the endothelium appeared normal in one busulfan-treated animal given platelet transfusions 9,000-7,000- E F FIGURE 4 Distribution of measurements of mean capillary wall thickness from each experimental preparation. A = normal; B = normal given prednisone; C = thrombocytopenia; D = prednisone followed by thrombocytopenia; and E and F = thrombocytopenia followed by low-dose and high-dose prednisone treatment, respectively.
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to maintain the platelet count >100,000/mm3.1 These observations lessen the contention that the observed endothelial abnormalities are secondary to the thrombocytopenia-inducing agent rather than to the thrombocytopenia itself.
Bleeding from thrombocytopenia occurs at the microvascular level (12) . The extravasation of red cells results in petechiae and purpura. Gore et al. (13) suggested that the extravasation took place between loosened interendothelial junctions. However, all junctions were structurally normal in the present study and other previous studies (2, 3) .
Normal capillaries supplying muscular tissue have a wall thickness ranging from 2,500 to 5,000 A and lack thin spots and fenestrations (10) . In this study, clinically observable bleeding was associated with the presence of microvascular thinning and the number of thin spots and fenestrations. Vesicles (Fig. 1) normally traverse endothelial walls and serve a transport mechanism (14) . Their diameter is 700-800 A. A thin spot of less thickness than these vesicles could potentially be bridged by a vesicle with resultant decreased hemostatic capabilities. Therefore, the number of thin spots was tabulated. It is important that neither fenestrations nor thin spots were detected in the walls of any vessels supplying muscular tissues in control rabbits.
By some mechanism, platelets enhance structural and functional integrity of normal endothelium (1, 2) . In earlier in vivo experiments, thrombocytopenic bleeding was rapidly and effectively arrested by the infusion of normal platelets (15, 16) . Human endothelial cells have now been successfully grown in tissue culture (17) . Investigators (18, 19) demonstrated that the addition ofplatelets to tissue culture medium enhanced the growth and replication ofcultured human umbilical vein endothelial cells. Others (20) demonstrated that contiguity of cultured endothelial cells was increased when platelets were added to the culture medium, but that neither DNA synthesis nor endothelial cell replication was increased.
Clinical evidence has suggested that adrenocorticosteroids may decrease the fragility of the microvasculature in thrombocytopenia even without an increase in platelet count (6) . Experimental evidence supporting this impression has been lacking until recently. Senyi and co-workers (21) found that hydrocortisone (25-100 mg/kg) parenterally administered 30 min before testing shortened the jugular vein bleeding time in thrombocytopenic rabbits and suggested that this was because of a local effect of the hydrocortisone on the vessel wall. Maca and associates (20) reported that dexamethasone added to tissue culture medium increased the contiguity of cultured endo-1 Unpublished observation. thelial cells from human umbilical vein without an increase in DNA synthesis. This effect was seen within 24 h after the addition of the steroid and was maximum by 72 h.
The present study demonstrates an association between clinically observable altered hemostasis and structural endothelial abnormalities during experimental thrombocytopenia induced by busulfan. The abnormal hemostasis and endothelial lesions were largely reversed or prevented by administering prednisone at the dosages and schedules employed. The mechanism by which platelets maintain normal microvascular endothelial cell structure and function is not understood. Similarly, these studies do not define the mechanism by which adrenocorticosteroids prevent or reverse endothelial alterations during thrombocytopenia. Although this study involves short-term experimental thrombocytopenia in an animal model, the data and clinical observations justify a trial of adrenocorticosteroids to decrease capillary fragility in human thrombocytopenia regardless of etiology.
